Emerging Europe
Emerging Europe Pharmaceuticals & Healthcare Insight provides country-by-country analysis of the key trends impacting the prescription, OTC and generic drugs industries across Emerging Europe. Emerging Europe Pharmaceuticals & Healthcare Insight includes competitive intelligence on the growth strategies of leading national and multinational companies, along with 5-year industry forecasts for each country. The service includes access to the very latest analysis, a searchable archive of articles and data and the ability to download PDFs of current and back issues.
›› To gain FREE online access for 14 days and to download a FREE PDF, click trial.
›› To receive 15 monthly pdf issues for the price of 12 and to gain immediate online access, click subscribe.
Ukraine / Industry
BMI View: Three main factors govern our outlook for Ukraine's pharmaceutical market in 2012 and 2013: the worsening economic growth prospects, the high potential for devaluation of the hryvnia and signs that the government will introduce a reference pricing system for medicines. While short-term real growth will face obstacles in the coming years, we maintain our positive long-term...
2012-02-01Switzerland / Industry
BMI View: We believe the long-awaited formation of a joint venture (JV) between Actavis and Bioton in the field of insulin production and commercialisation is highly favourable for...
2012-02-01Romania / Industry
BMI View: While there has been no immediate impact on Romania's health system following the withdrawal of the draft healthcare reform bill, the development is bad news for private healthcare...
2012-01-16Industry Developments
Ukraine
BMI View: Three main factors govern our outlook for Ukraine's pharmaceutical market in 2012 and 2013: the worsening economic growth prospects, the high potential for devaluation of...
2012-02-01Switzerland
BMI View: We believe the long-awaited formation of a joint venture (JV) between Actavis and Bioton in the field of insulin production and commercialisation is highly favourable for...
2012-02-01Romania
BMI View: While there has been no immediate impact on Romania's health system following the withdrawal of the draft healthcare reform bill, the development is bad news for private healthcare...
2012-01-16Turkey
BMI View: While the Turkish pharmaceutical industry has achieved some concessions following additional price cuts and public discounts announced in November 2011, the impact of the...
2012-01-06
